Form 8-K - Current report:
SEC Accession No. 0001615219-21-000017
Filing Date
2021-02-17
Accepted
2021-02-17 16:00:33
Documents
6
Period of Report
2021-02-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K slrx-8xk021721pressrelease.htm 8-K 24848
2 EX-99.1 slrxpr02172021.htm EX-99.1 18221
3 image_01.jpg GRAPHIC 89
4 image_01a.jpg GRAPHIC 132
5 image_11a.jpg GRAPHIC 39936
6 image_11b.jpg GRAPHIC 137
  Complete submission text file 0001615219-21-000017.txt   100230
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 21644639
SIC: 2834 Pharmaceutical Preparations